Latest AstraZeneca News & Updates

See the latest news and media coverage for AstraZeneca. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AstraZeneca

Science-led biopharmaceutical company

astrazeneca.com
Headquarters
Cambridge, United Kingdom
Company type
Public company
Number of employees
75,000+

Latest news about AstraZeneca

Company announcements

  • AstraZeneca

    AstraZeneca's Truqap receives FDA ODAC recommendation

    The committee voted 7-1 in favor of Truqap plus abiraterone and ADT for PTEN-deficient mHSPC based on CAPItello-281 trial results showing improved rPFS.

  • AstraZeneca

    AstraZeneca reports FDA ODAC's mixed vote on camizestrant

    The committee voted 3-6 against majority on benefit-risk for camizestrant plus CDK4/6 inhibitor in HR-positive breast cancer with ESR1 mutation. AstraZeneca remains committed and awaits FDA decision.

  • AstraZeneca

    AstraZeneca delivers strong Q1 2026 growth

    Total Revenue exceeds $15 billion. They advance Phase III programmes and stay on track for 2030 ambitions.

  • AstraZeneca

    AstraZeneca reports Q1 2026 results

    Total revenue rises 8% to $15.3bn. Core EPS increases 5% to $2.58. Company reconfirms FY 2026 guidance.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about AstraZeneca

Track AstraZeneca and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.